MYLAN's $ 50 MIL. ACQUISITION OF DOW B. HICKAM IS NEXT STAGE IN GROWTH OF BRANDNAME DRUG BUSINESS; HICKAM BRINGS 70 SALES REPS AND $ 18 MIL. SALES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".